

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 4.82817380 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.82817380 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.82817380 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.82817380 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 4.82817380 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.82817380 |
| 7 | regulation of integrin activation (GO:0033623) | 4.21704754 |
| 8 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.19113858 |
| 9 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 4.12558494 |
| 10 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.97803020 |
| 11 | regulation of gene silencing by miRNA (GO:0060964) | 3.97803020 |
| 12 | regulation of gene silencing by RNA (GO:0060966) | 3.97803020 |
| 13 | protein localization to endosome (GO:0036010) | 3.91747468 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.89398673 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 3.76286812 |
| 16 | barbed-end actin filament capping (GO:0051016) | 3.72783439 |
| 17 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.62124951 |
| 18 | stress fiber assembly (GO:0043149) | 3.51980056 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.43364397 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 3.41945655 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.38577809 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.38577809 |
| 23 | apoptotic cell clearance (GO:0043277) | 3.37706439 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35997394 |
| 25 | heterochromatin organization (GO:0070828) | 3.30403253 |
| 26 | pre-miRNA processing (GO:0031054) | 3.26747635 |
| 27 | negative regulation of granulocyte differentiation (GO:0030853) | 3.26486827 |
| 28 | embryonic process involved in female pregnancy (GO:0060136) | 3.22866421 |
| 29 | apoptotic process involved in morphogenesis (GO:0060561) | 3.22496531 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.17515340 |
| 31 | B cell mediated immunity (GO:0019724) | 3.12678140 |
| 32 | detection of other organism (GO:0098543) | 3.11995088 |
| 33 | response to peptidoglycan (GO:0032494) | 3.09215080 |
| 34 | regulation of hippo signaling (GO:0035330) | 3.08832447 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.06350947 |
| 36 | nodal signaling pathway (GO:0038092) | 3.06304036 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.05931604 |
| 38 | mannose metabolic process (GO:0006013) | 3.04930067 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.04454508 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.02959945 |
| 41 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02819412 |
| 42 | detection of external biotic stimulus (GO:0098581) | 3.00674769 |
| 43 | response to laminar fluid shear stress (GO:0034616) | 2.99311695 |
| 44 | vagina development (GO:0060068) | 2.97801769 |
| 45 | positive regulation of p38MAPK cascade (GO:1900745) | 2.95208763 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94217662 |
| 47 | regulation of interferon-alpha production (GO:0032647) | 2.92754909 |
| 48 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92485273 |
| 49 | detection of bacterium (GO:0016045) | 2.91808445 |
| 50 | skin morphogenesis (GO:0043589) | 2.91544080 |
| 51 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.91201329 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88851572 |
| 53 | modulation by symbiont of host cellular process (GO:0044068) | 2.86951994 |
| 54 | response to host immune response (GO:0052572) | 2.86897245 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86897245 |
| 56 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.84986272 |
| 57 | positive regulation of receptor recycling (GO:0001921) | 2.83612163 |
| 58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.82529571 |
| 59 | regulation of early endosome to late endosome transport (GO:2000641) | 2.82511125 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 2.82313166 |
| 61 | positive regulation of T cell apoptotic process (GO:0070234) | 2.81218814 |
| 62 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.80029132 |
| 63 | regulation of macrophage cytokine production (GO:0010935) | 2.79552062 |
| 64 | regulation of cholesterol storage (GO:0010885) | 2.78884573 |
| 65 | regulation of extracellular matrix disassembly (GO:0010715) | 2.75557301 |
| 66 | embryonic placenta development (GO:0001892) | 2.75464804 |
| 67 | microglial cell activation (GO:0001774) | 2.75440735 |
| 68 | response to host (GO:0075136) | 2.72684920 |
| 69 | response to host defenses (GO:0052200) | 2.72684920 |
| 70 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72684920 |
| 71 | hyaluronan catabolic process (GO:0030214) | 2.72676772 |
| 72 | histone H4-K12 acetylation (GO:0043983) | 2.72550288 |
| 73 | regulation of mononuclear cell migration (GO:0071675) | 2.72243207 |
| 74 | positive regulation of interferon-beta production (GO:0032728) | 2.71810352 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 2.67495280 |
| 76 | cortical actin cytoskeleton organization (GO:0030866) | 2.66647010 |
| 77 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.66611313 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.65041476 |
| 79 | detection of biotic stimulus (GO:0009595) | 2.64551730 |
| 80 | pinocytosis (GO:0006907) | 2.64117355 |
| 81 | determination of adult lifespan (GO:0008340) | 2.63501205 |
| 82 | trophectodermal cell differentiation (GO:0001829) | 2.62927940 |
| 83 | negative regulation of histone methylation (GO:0031061) | 2.62653625 |
| 84 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.61988570 |
| 85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61029126 |
| 86 | regulation of translational fidelity (GO:0006450) | 2.59662398 |
| 87 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.59304548 |
| 88 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58203304 |
| 89 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.58035248 |
| 90 | adherens junction assembly (GO:0034333) | 2.57527655 |
| 91 | basic amino acid transport (GO:0015802) | 2.56315996 |
| 92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.55820095 |
| 93 | response to UV-C (GO:0010225) | 2.55408664 |
| 94 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.54916223 |
| 95 | focal adhesion assembly (GO:0048041) | 2.53956384 |
| 96 | cell-substrate adherens junction assembly (GO:0007045) | 2.53956384 |
| 97 | paraxial mesoderm development (GO:0048339) | 2.52361469 |
| 98 | NIK/NF-kappaB signaling (GO:0038061) | 2.51206262 |
| 99 | I-kappaB phosphorylation (GO:0007252) | 2.51196444 |
| 100 | female genitalia development (GO:0030540) | 2.50933407 |
| 101 | nuclear pore organization (GO:0006999) | 2.50203598 |
| 102 | cell-substrate junction assembly (GO:0007044) | 2.49342002 |
| 103 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49331310 |
| 104 | positive regulation of macrophage cytokine production (GO:0060907) | 2.49022926 |
| 105 | germinal center formation (GO:0002467) | 2.48615739 |
| 106 | cellular extravasation (GO:0045123) | 2.48487586 |
| 107 | cellular response to virus (GO:0098586) | 2.46572033 |
| 108 | nuclear pore complex assembly (GO:0051292) | 2.44150178 |
| 109 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.43743146 |
| 110 | neutrophil activation involved in immune response (GO:0002283) | 2.42818506 |
| 111 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.42504977 |
| 112 | mitotic nuclear envelope disassembly (GO:0007077) | 2.42428606 |
| 113 | Golgi transport vesicle coating (GO:0048200) | 2.41838316 |
| 114 | COPI coating of Golgi vesicle (GO:0048205) | 2.41838316 |
| 115 | NLS-bearing protein import into nucleus (GO:0006607) | 2.41812513 |
| 116 | negative regulation of gene silencing (GO:0060969) | 2.41617546 |
| 117 | positive regulation of protein dephosphorylation (GO:0035307) | 2.41051680 |
| 118 | regulation of gene silencing (GO:0060968) | 2.39850267 |
| 119 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.37978872 |
| 120 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37210767 |
| 121 | basement membrane organization (GO:0071711) | 2.34949935 |
| 122 | protein localization to kinetochore (GO:0034501) | 2.34675894 |
| 123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.34651113 |
| 124 | cortical cytoskeleton organization (GO:0030865) | 2.34636277 |
| 125 | interferon-gamma secretion (GO:0072643) | 2.34329284 |
| 126 | positive regulation of protein homooligomerization (GO:0032464) | 2.34001389 |
| 127 | macrophage activation (GO:0042116) | 2.33718022 |
| 128 | regulation of regulated secretory pathway (GO:1903305) | 2.33471555 |
| 129 | hypotonic response (GO:0006971) | 2.33229352 |
| 130 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.32772460 |
| 131 | leukocyte aggregation (GO:0070486) | 2.32058225 |
| 132 | mRNA stabilization (GO:0048255) | 2.31790484 |
| 133 | RNA stabilization (GO:0043489) | 2.31790484 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.31266435 |
| 135 | wound healing, spreading of epidermal cells (GO:0035313) | 2.30688953 |
| 136 | negative regulation of interleukin-6 production (GO:0032715) | 2.30488195 |
| 137 | positive regulation of protein oligomerization (GO:0032461) | 2.30368520 |
| 138 | negative regulation of interleukin-8 production (GO:0032717) | 2.30230050 |
| 139 | nuclear envelope disassembly (GO:0051081) | 2.28768941 |
| 140 | membrane disassembly (GO:0030397) | 2.28768941 |
| 141 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27079490 |
| 142 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.26721071 |
| 143 | negative regulation of type 2 immune response (GO:0002829) | 2.26422550 |
| 144 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.25908702 |
| 145 | pore complex assembly (GO:0046931) | 2.25861595 |
| 146 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.25467101 |
| 147 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.25293524 |
| 148 | pentose-phosphate shunt (GO:0006098) | 2.25215449 |
| 149 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.24727572 |
| 150 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.24143989 |
| 151 | establishment of apical/basal cell polarity (GO:0035089) | 2.23606031 |
| 152 | intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630) | 2.23363281 |
| 153 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.23185299 |
| 154 | apoptotic process involved in development (GO:1902742) | 2.22901851 |
| 155 | regulation of type 2 immune response (GO:0002828) | 2.21610096 |
| 156 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.21534601 |
| 157 | developmental programmed cell death (GO:0010623) | 2.20913125 |
| 158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.20674659 |
| 159 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.18677735 |
| 160 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17171074 |
| 161 | signal complex assembly (GO:0007172) | 2.16619252 |
| 162 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.15548766 |
| 163 | granulocyte activation (GO:0036230) | 2.15155586 |
| 164 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.15051649 |
| 165 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.14906399 |
| 166 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.14812305 |
| 167 | cellular response to type I interferon (GO:0071357) | 2.14464335 |
| 168 | type I interferon signaling pathway (GO:0060337) | 2.14464335 |
| 169 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.13835326 |
| 170 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.13578270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.20226624 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.91174107 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25175308 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.92343226 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.91924794 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.88404210 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.88404210 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.88404210 |
| 9 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42499893 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.41144865 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.25397819 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.25330675 |
| 13 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.23700281 |
| 14 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.08299916 |
| 15 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.05712636 |
| 16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.05045683 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89565281 |
| 18 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.84607644 |
| 19 | KDM2B_26808549_Chip-Seq_K562_Human | 1.82361367 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82215663 |
| 21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.74504704 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73669383 |
| 23 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.73570026 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73163425 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72506860 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.71638705 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65473916 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.65009433 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63038663 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61354289 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60090130 |
| 32 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59186634 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55241670 |
| 34 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52984854 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51830617 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51407393 |
| 37 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.51128114 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.49859837 |
| 39 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.47209448 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45589124 |
| 41 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.45578738 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44144358 |
| 43 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43937233 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43652732 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43380324 |
| 46 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42357918 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42115004 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40728323 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.40604983 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40556774 |
| 51 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38771155 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38466043 |
| 53 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.38071901 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.37534053 |
| 55 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.37267484 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36845445 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36671230 |
| 58 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.36563398 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36553989 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36151465 |
| 61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34579841 |
| 62 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29734664 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28755280 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27987693 |
| 65 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.27436169 |
| 66 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27147144 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26359292 |
| 68 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26091544 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.25826384 |
| 70 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.25273434 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24181656 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23430203 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22900873 |
| 74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.21241384 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21053973 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.21016098 |
| 77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20586533 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19169710 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.18902995 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16846884 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16792395 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16188236 |
| 83 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15439104 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15366654 |
| 85 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15241762 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14738279 |
| 87 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.14378597 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13739328 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13330278 |
| 90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13198654 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13098333 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13047140 |
| 93 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.12962772 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12944235 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12796843 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12341800 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11738830 |
| 98 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11258788 |
| 99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.10978940 |
| 100 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10964955 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09917641 |
| 102 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09310639 |
| 103 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08971041 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08903132 |
| 105 | * P68_20966046_ChIP-Seq_HELA_Human | 1.08682008 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08589524 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08515426 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07775361 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06889731 |
| 110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06883687 |
| 111 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06525319 |
| 112 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.06422856 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06340709 |
| 114 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06060385 |
| 115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.06058539 |
| 116 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.05612164 |
| 117 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05101019 |
| 118 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04701805 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.04136487 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03474053 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02597365 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02549588 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01904087 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01258135 |
| 125 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00945429 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.00142556 |
| 127 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00130811 |
| 128 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99898001 |
| 129 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99163392 |
| 130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98555261 |
| 131 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98183071 |
| 132 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.96701559 |
| 133 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96514815 |
| 134 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96328504 |
| 135 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96117665 |
| 136 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93916248 |
| 137 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93464935 |
| 138 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.92887649 |
| 139 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92051331 |
| 140 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.91926687 |
| 141 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.91548717 |
| 142 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.91301454 |
| 143 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.91108424 |
| 144 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.90670049 |
| 145 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90488009 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90259852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.03516460 |
| 2 | MP0010352_gastrointestinal_tract_polyps | 2.87928982 |
| 3 | MP0009278_abnormal_bone_marrow | 2.77986809 |
| 4 | MP0005076_abnormal_cell_differentiation | 2.75220187 |
| 5 | MP0009840_abnormal_foam_cell | 2.73227529 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.57006925 |
| 7 | MP0003724_increased_susceptibility_to | 2.56775179 |
| 8 | MP0003566_abnormal_cell_adhesion | 2.51765573 |
| 9 | MP0003436_decreased_susceptibility_to | 2.48907393 |
| 10 | MP0003303_peritoneal_inflammation | 2.31781525 |
| 11 | MP0001958_emphysema | 2.25143552 |
| 12 | MP0008260_abnormal_autophagy | 2.22831116 |
| 13 | MP0002254_reproductive_system_inflammat | 2.14933654 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.14393549 |
| 15 | MP0005451_abnormal_body_composition | 2.06595314 |
| 16 | MP0010307_abnormal_tumor_latency | 2.03329775 |
| 17 | MP0001835_abnormal_antigen_presentation | 1.99745359 |
| 18 | MP0003172_abnormal_lysosome_physiology | 1.91383358 |
| 19 | MP0005023_abnormal_wound_healing | 1.85553232 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 1.76288199 |
| 21 | MP0006082_CNS_inflammation | 1.71293473 |
| 22 | MP0001545_abnormal_hematopoietic_system | 1.68482865 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.68482865 |
| 24 | MP0003111_abnormal_nucleus_morphology | 1.67777001 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.66001611 |
| 26 | MP0003448_altered_tumor_morphology | 1.63363225 |
| 27 | MP0008007_abnormal_cellular_replicative | 1.55682152 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.52285164 |
| 29 | MP0000858_altered_metastatic_potential | 1.50722734 |
| 30 | MP0003329_amyloid_beta_deposits | 1.50625825 |
| 31 | MP0002877_abnormal_melanocyte_morpholog | 1.50582695 |
| 32 | MP0004947_skin_inflammation | 1.49426712 |
| 33 | MP0002419_abnormal_innate_immunity | 1.46940274 |
| 34 | MP0003077_abnormal_cell_cycle | 1.44288653 |
| 35 | MP0005275_abnormal_skin_tensile | 1.43522739 |
| 36 | MP0000604_amyloidosis | 1.42359962 |
| 37 | MP0004957_abnormal_blastocyst_morpholog | 1.41319998 |
| 38 | MP0008057_abnormal_DNA_replication | 1.41137804 |
| 39 | MP0009785_altered_susceptibility_to | 1.39521908 |
| 40 | MP0002405_respiratory_system_inflammati | 1.38014806 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.37163497 |
| 42 | MP0004272_abnormal_basement_membrane | 1.35556788 |
| 43 | MP0001790_abnormal_immune_system | 1.35128403 |
| 44 | MP0005387_immune_system_phenotype | 1.35128403 |
| 45 | MP0004510_myositis | 1.34339803 |
| 46 | MP0003690_abnormal_glial_cell | 1.32372251 |
| 47 | MP0001542_abnormal_bone_strength | 1.31417333 |
| 48 | MP0000685_abnormal_immune_system | 1.30734427 |
| 49 | MP0002452_abnormal_antigen_presenting | 1.29979398 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.29649324 |
| 51 | MP0003890_abnormal_embryonic-extraembry | 1.27089662 |
| 52 | MP0001849_ear_inflammation | 1.26980068 |
| 53 | MP0000343_altered_response_to | 1.25803830 |
| 54 | MP0002086_abnormal_extraembryonic_tissu | 1.24526976 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.24118849 |
| 56 | MP0000350_abnormal_cell_proliferation | 1.23726292 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.23559877 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.22919852 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.20382660 |
| 60 | MP0001800_abnormal_humoral_immune | 1.19139353 |
| 61 | MP0005164_abnormal_response_to | 1.16682555 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.14809298 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.13178579 |
| 64 | MP0005380_embryogenesis_phenotype | 1.13178579 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 1.12718170 |
| 66 | MP0002060_abnormal_skin_morphology | 1.12621326 |
| 67 | MP0008004_abnormal_stomach_pH | 1.12235570 |
| 68 | MP0001915_intracranial_hemorrhage | 1.11951011 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.09746923 |
| 70 | MP0005025_abnormal_response_to | 1.07584700 |
| 71 | MP0003279_aneurysm | 1.06789129 |
| 72 | MP0002088_abnormal_embryonic_growth/wei | 1.06163116 |
| 73 | MP0003091_abnormal_cell_migration | 1.05979526 |
| 74 | MP0003984_embryonic_growth_retardation | 1.05585656 |
| 75 | MP0003075_altered_response_to | 1.05262022 |
| 76 | MP0002723_abnormal_immune_serum | 1.04707777 |
| 77 | MP0005409_darkened_coat_color | 1.03905578 |
| 78 | MP0005666_abnormal_adipose_tissue | 1.03789742 |
| 79 | MP0010030_abnormal_orbit_morphology | 1.03729350 |
| 80 | MP0001730_embryonic_growth_arrest | 1.03223408 |
| 81 | MP0005166_decreased_susceptibility_to | 1.01630248 |
| 82 | MP0000569_abnormal_digit_pigmentation | 0.99930924 |
| 83 | MP0003828_pulmonary_edema | 0.99593468 |
| 84 | MP0001697_abnormal_embryo_size | 0.98930374 |
| 85 | MP0002085_abnormal_embryonic_tissue | 0.98702882 |
| 86 | MP0002148_abnormal_hypersensitivity_rea | 0.98373423 |
| 87 | MP0004197_abnormal_fetal_growth/weight/ | 0.98294415 |
| 88 | MP0002796_impaired_skin_barrier | 0.96829421 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.96626632 |
| 90 | MP0010094_abnormal_chromosome_stability | 0.95826698 |
| 91 | MP0005375_adipose_tissue_phenotype | 0.95492685 |
| 92 | MP0002084_abnormal_developmental_patter | 0.94978137 |
| 93 | MP0001819_abnormal_immune_cell | 0.94686781 |
| 94 | MP0000767_abnormal_smooth_muscle | 0.93513291 |
| 95 | MP0003045_fibrosis | 0.92665393 |
| 96 | MP0005503_abnormal_tendon_morphology | 0.92624310 |
| 97 | MP0002420_abnormal_adaptive_immunity | 0.92431005 |
| 98 | MP0000490_abnormal_crypts_of | 0.92389636 |
| 99 | MP0005390_skeleton_phenotype | 0.91617430 |
| 100 | MP0000689_abnormal_spleen_morphology | 0.91072860 |
| 101 | MP0005310_abnormal_salivary_gland | 0.89591664 |
| 102 | MP0000371_diluted_coat_color | 0.89046551 |
| 103 | MP0003795_abnormal_bone_structure | 0.88896039 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.88706768 |
| 105 | MP0001348_abnormal_lacrimal_gland | 0.87854128 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.87532743 |
| 107 | MP0002933_joint_inflammation | 0.87319988 |
| 108 | MP0004883_abnormal_blood_vessel | 0.87225630 |
| 109 | MP0005621_abnormal_cell_physiology | 0.86213520 |
| 110 | MP0008469_abnormal_protein_level | 0.85920021 |
| 111 | MP0001853_heart_inflammation | 0.85782779 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.85751761 |
| 113 | MP0000751_myopathy | 0.85245997 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.83788310 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.83696413 |
| 116 | MP0002722_abnormal_immune_system | 0.83646978 |
| 117 | MP0006054_spinal_hemorrhage | 0.83145763 |
| 118 | MP0009764_decreased_sensitivity_to | 0.82456934 |
| 119 | MP0002295_abnormal_pulmonary_circulatio | 0.82352583 |
| 120 | MP0002396_abnormal_hematopoietic_system | 0.82260711 |
| 121 | MP0000920_abnormal_myelination | 0.82244450 |
| 122 | MP0002398_abnormal_bone_marrow | 0.82019877 |
| 123 | MP0004233_abnormal_muscle_weight | 0.81862195 |
| 124 | MP0005595_abnormal_vascular_smooth | 0.81329066 |
| 125 | MP0000313_abnormal_cell_death | 0.81197243 |
| 126 | MP0002080_prenatal_lethality | 0.81040977 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.80793328 |
| 128 | MP0005508_abnormal_skeleton_morphology | 0.79086672 |
| 129 | MP0008874_decreased_physiological_sensi | 0.78787240 |
| 130 | MP0004858_abnormal_nervous_system | 0.78738835 |
| 131 | MP0005165_increased_susceptibility_to | 0.78675397 |
| 132 | MP0004133_heterotaxia | 0.78415980 |
| 133 | MP0000249_abnormal_blood_vessel | 0.78407001 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.78096491 |
| 135 | MP0000750_abnormal_muscle_regeneration | 0.77037144 |
| 136 | MP0000678_abnormal_parathyroid_gland | 0.76448064 |
| 137 | MP0002925_abnormal_cardiovascular_devel | 0.76344714 |
| 138 | MP0000716_abnormal_immune_system | 0.75900938 |
| 139 | MP0000733_abnormal_muscle_development | 0.72940682 |
| 140 | MP0002429_abnormal_blood_cell | 0.72417995 |
| 141 | MP0001851_eye_inflammation | 0.71210970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.15156669 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.78205307 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.50292049 |
| 4 | Agnosia (HP:0010524) | 3.28507427 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.09574530 |
| 6 | Cerebral aneurysm (HP:0004944) | 2.99439522 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.98437367 |
| 8 | Increased connective tissue (HP:0009025) | 2.70131316 |
| 9 | Myocardial infarction (HP:0001658) | 2.69994558 |
| 10 | Glomerulonephritis (HP:0000099) | 2.69147395 |
| 11 | Hand muscle atrophy (HP:0009130) | 2.63817487 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59801938 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59801938 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59801938 |
| 15 | Increased variability in muscle fiber diameter (HP:0003557) | 2.58676661 |
| 16 | Dilatation of the ascending aorta (HP:0005111) | 2.58020643 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 2.57084533 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55528887 |
| 19 | Mucopolysacchariduria (HP:0008155) | 2.55528887 |
| 20 | Ependymoma (HP:0002888) | 2.55309586 |
| 21 | Aortic aneurysm (HP:0004942) | 2.54838458 |
| 22 | Urethral obstruction (HP:0000796) | 2.54419795 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.52499710 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.52479423 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.52479423 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.52479423 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.49212344 |
| 28 | Vascular tortuosity (HP:0004948) | 2.48462716 |
| 29 | Ankle contracture (HP:0006466) | 2.46998337 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.46425053 |
| 31 | Amyloidosis (HP:0011034) | 2.40272568 |
| 32 | Abnormality of complement system (HP:0005339) | 2.39794353 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.37522197 |
| 34 | Pustule (HP:0200039) | 2.36503337 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.35040871 |
| 36 | Arterial tortuosity (HP:0005116) | 2.34445671 |
| 37 | Peritonitis (HP:0002586) | 2.33724833 |
| 38 | Spinal rigidity (HP:0003306) | 2.33700591 |
| 39 | Rib fusion (HP:0000902) | 2.32233194 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.31773328 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.31709241 |
| 42 | Distal lower limb amyotrophy (HP:0008944) | 2.31246971 |
| 43 | Upper limb amyotrophy (HP:0009129) | 2.29390451 |
| 44 | Distal upper limb amyotrophy (HP:0007149) | 2.29390451 |
| 45 | Spinal muscular atrophy (HP:0007269) | 2.28622166 |
| 46 | Fragile skin (HP:0001030) | 2.24334079 |
| 47 | Upper motor neuron abnormality (HP:0002127) | 2.24014537 |
| 48 | Genu recurvatum (HP:0002816) | 2.23662223 |
| 49 | Aortic dissection (HP:0002647) | 2.23616274 |
| 50 | Axonal loss (HP:0003447) | 2.19095629 |
| 51 | Disinhibition (HP:0000734) | 2.18692731 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.17961815 |
| 53 | Aneurysm (HP:0002617) | 2.16839140 |
| 54 | Hyperacusis (HP:0010780) | 2.16370023 |
| 55 | Complement deficiency (HP:0004431) | 2.15821261 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.15255818 |
| 57 | Mitral regurgitation (HP:0001653) | 2.14991376 |
| 58 | Wormian bones (HP:0002645) | 2.14784455 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.14562756 |
| 60 | Gingivitis (HP:0000230) | 2.14107183 |
| 61 | Intestinal fistula (HP:0100819) | 2.14079490 |
| 62 | Atrophic scars (HP:0001075) | 2.13014637 |
| 63 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.09963225 |
| 64 | Nuclear cataract (HP:0100018) | 2.08457798 |
| 65 | Achilles tendon contracture (HP:0001771) | 2.07950626 |
| 66 | Prostate neoplasm (HP:0100787) | 2.06002977 |
| 67 | Disproportionate tall stature (HP:0001519) | 2.05058733 |
| 68 | Short humerus (HP:0005792) | 2.04418873 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.04100874 |
| 70 | Thin bony cortex (HP:0002753) | 2.04094436 |
| 71 | Broad face (HP:0000283) | 2.03256411 |
| 72 | Increased IgE level (HP:0003212) | 2.01703876 |
| 73 | Slender build (HP:0001533) | 2.01566598 |
| 74 | Abnormality of the astrocytes (HP:0100707) | 2.01202994 |
| 75 | Astrocytoma (HP:0009592) | 2.01202994 |
| 76 | Ulnar bowing (HP:0003031) | 2.01135363 |
| 77 | Orchitis (HP:0100796) | 2.00588443 |
| 78 | Pathologic fracture (HP:0002756) | 1.99915951 |
| 79 | Broad metatarsal (HP:0001783) | 1.99743183 |
| 80 | Polycythemia (HP:0001901) | 1.98885365 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97519286 |
| 82 | Cervical subluxation (HP:0003308) | 1.97173997 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 1.96866853 |
| 84 | Bladder diverticulum (HP:0000015) | 1.95488691 |
| 85 | Vertebral compression fractures (HP:0002953) | 1.95032641 |
| 86 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.94652529 |
| 87 | Vaginal fistula (HP:0004320) | 1.94534764 |
| 88 | Nephritis (HP:0000123) | 1.94476859 |
| 89 | Selective tooth agenesis (HP:0001592) | 1.90409978 |
| 90 | Rectovaginal fistula (HP:0000143) | 1.90267137 |
| 91 | Rectal fistula (HP:0100590) | 1.90267137 |
| 92 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89484819 |
| 93 | Protrusio acetabuli (HP:0003179) | 1.88802458 |
| 94 | Fused cervical vertebrae (HP:0002949) | 1.88612882 |
| 95 | Shallow orbits (HP:0000586) | 1.88327140 |
| 96 | Osteolytic defects of the hand bones (HP:0009699) | 1.86289727 |
| 97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86289727 |
| 98 | Emphysema (HP:0002097) | 1.84789425 |
| 99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83973411 |
| 100 | Polygenic inheritance (HP:0010982) | 1.83290150 |
| 101 | Abnormality of the Achilles tendon (HP:0005109) | 1.82918752 |
| 102 | Hematochezia (HP:0002573) | 1.82501826 |
| 103 | Biconcave vertebral bodies (HP:0004586) | 1.81504430 |
| 104 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.80031111 |
| 105 | Vertebral hypoplasia (HP:0008417) | 1.80031111 |
| 106 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.79177388 |
| 107 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.78535194 |
| 108 | Gastrointestinal carcinoma (HP:0002672) | 1.78535194 |
| 109 | Retrobulbar optic neuritis (HP:0100654) | 1.77681690 |
| 110 | Optic neuritis (HP:0100653) | 1.77681690 |
| 111 | Spinal cord lesions (HP:0100561) | 1.77637168 |
| 112 | Syringomyelia (HP:0003396) | 1.77637168 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.76220696 |
| 114 | Personality changes (HP:0000751) | 1.75439647 |
| 115 | Hypertriglyceridemia (HP:0002155) | 1.75336923 |
| 116 | Obstructive lung disease (HP:0006536) | 1.75169134 |
| 117 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75169134 |
| 118 | Difficulty climbing stairs (HP:0003551) | 1.74785162 |
| 119 | Vertebral fusion (HP:0002948) | 1.73536070 |
| 120 | Myositis (HP:0100614) | 1.73248264 |
| 121 | Metaphyseal cupping (HP:0003021) | 1.73238664 |
| 122 | Joint stiffness (HP:0001387) | 1.73082136 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.71462239 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.70705012 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.69952994 |
| 126 | Long palpebral fissure (HP:0000637) | 1.69353097 |
| 127 | Urticaria (HP:0001025) | 1.69347159 |
| 128 | Recurrent fungal infections (HP:0002841) | 1.68949343 |
| 129 | Asymmetric septal hypertrophy (HP:0001670) | 1.68850553 |
| 130 | Joint laxity (HP:0001388) | 1.68716658 |
| 131 | Type 1 muscle fiber predominance (HP:0003803) | 1.68129325 |
| 132 | Neuronal loss in central nervous system (HP:0002529) | 1.67950278 |
| 133 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.67877991 |
| 134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67732869 |
| 135 | Turricephaly (HP:0000262) | 1.67227061 |
| 136 | Hemorrhage of the eye (HP:0011885) | 1.66930862 |
| 137 | Purpura (HP:0000979) | 1.66568765 |
| 138 | Neoplasm of the oral cavity (HP:0100649) | 1.65067007 |
| 139 | Tetraparesis (HP:0002273) | 1.61528968 |
| 140 | Mitral valve prolapse (HP:0001634) | 1.60052672 |
| 141 | Peripheral demyelination (HP:0011096) | 1.59094729 |
| 142 | Chromsome breakage (HP:0040012) | 1.57283579 |
| 143 | Spondylolisthesis (HP:0003302) | 1.55395949 |
| 144 | Increased CSF protein (HP:0002922) | 1.54836604 |
| 145 | Premature rupture of membranes (HP:0001788) | 1.54441485 |
| 146 | Loss of speech (HP:0002371) | 1.53181119 |
| 147 | Cellulitis (HP:0100658) | 1.52777718 |
| 148 | Esophageal varix (HP:0002040) | 1.52137492 |
| 149 | Orthostatic hypotension (HP:0001278) | 1.51765008 |
| 150 | Leiomyosarcoma (HP:0100243) | 1.51042530 |
| 151 | Uterine leiomyosarcoma (HP:0002891) | 1.51042530 |
| 152 | Recurrent skin infections (HP:0001581) | 1.49879810 |
| 153 | Large earlobe (HP:0009748) | 1.47907561 |
| 154 | Increased density of long bones (HP:0006392) | 1.47611901 |
| 155 | Bone pain (HP:0002653) | 1.46656657 |
| 156 | Premature ovarian failure (HP:0008209) | 1.43746629 |
| 157 | Distal lower limb muscle weakness (HP:0009053) | 1.43182030 |
| 158 | Blue sclerae (HP:0000592) | 1.42459824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 4.87254808 |
| 2 | ERN1 | 3.63780046 |
| 3 | PRPF4B | 3.28779375 |
| 4 | EPHA2 | 2.50122057 |
| 5 | STK10 | 2.46923247 |
| 6 | MAP3K10 | 2.41977573 |
| 7 | TGFBR2 | 2.33097842 |
| 8 | TRIB3 | 2.28532309 |
| 9 | SMG1 | 2.11823961 |
| 10 | ICK | 1.83856981 |
| 11 | TYK2 | 1.74203615 |
| 12 | IRAK3 | 1.71163146 |
| 13 | BMX | 1.63220105 |
| 14 | PAK4 | 1.61282521 |
| 15 | MAP3K13 | 1.60498781 |
| 16 | LATS2 | 1.58252208 |
| 17 | TBK1 | 1.48096401 |
| 18 | MAP3K14 | 1.45095930 |
| 19 | IKBKB | 1.43018856 |
| 20 | TESK1 | 1.41579803 |
| 21 | CHUK | 1.39379182 |
| 22 | CDC42BPA | 1.38424951 |
| 23 | CDK7 | 1.36913868 |
| 24 | LATS1 | 1.33570600 |
| 25 | TTK | 1.33004433 |
| 26 | CSK | 1.32884749 |
| 27 | RPS6KA4 | 1.32788586 |
| 28 | PTK6 | 1.32057953 |
| 29 | PKN2 | 1.30624399 |
| 30 | CDK6 | 1.29176673 |
| 31 | FGFR4 | 1.28084347 |
| 32 | RIPK1 | 1.26417006 |
| 33 | BLK | 1.25583897 |
| 34 | MAP3K1 | 1.25297844 |
| 35 | MARK2 | 1.23302141 |
| 36 | PIM1 | 1.22139669 |
| 37 | ARAF | 1.21608664 |
| 38 | DDR2 | 1.20255128 |
| 39 | NEK2 | 1.19081395 |
| 40 | CAMK1D | 1.18638186 |
| 41 | MTOR | 1.18267247 |
| 42 | MATK | 1.16741550 |
| 43 | STK3 | 1.14057813 |
| 44 | TAOK1 | 1.10780190 |
| 45 | MAP3K8 | 1.10575870 |
| 46 | MAPK15 | 1.10465715 |
| 47 | MAP3K11 | 1.08009254 |
| 48 | EPHB1 | 1.07359062 |
| 49 | PIM2 | 1.07133027 |
| 50 | CDK4 | 1.05201704 |
| 51 | SIK3 | 1.04502818 |
| 52 | PTK2 | 1.03462093 |
| 53 | EEF2K | 1.03088398 |
| 54 | DMPK | 1.03029589 |
| 55 | IRAK2 | 0.98678155 |
| 56 | MAP2K3 | 0.95559109 |
| 57 | TTN | 0.95022193 |
| 58 | MAP3K3 | 0.94321240 |
| 59 | PDPK1 | 0.94109109 |
| 60 | TAOK2 | 0.93860568 |
| 61 | ALK | 0.93248423 |
| 62 | FGR | 0.92626484 |
| 63 | RPS6KA2 | 0.90671133 |
| 64 | MOS | 0.88192050 |
| 65 | NME2 | 0.88069816 |
| 66 | CSF1R | 0.87470752 |
| 67 | PDGFRA | 0.84875927 |
| 68 | NTRK1 | 0.83888702 |
| 69 | STK38 | 0.83661608 |
| 70 | TNK2 | 0.83626196 |
| 71 | MAP3K9 | 0.80310891 |
| 72 | MAP3K6 | 0.80067103 |
| 73 | PRKG2 | 0.78200918 |
| 74 | JAK2 | 0.77828053 |
| 75 | FES | 0.75348605 |
| 76 | TYRO3 | 0.74453860 |
| 77 | JAK3 | 0.71496433 |
| 78 | STK4 | 0.71106981 |
| 79 | BRD4 | 0.70894252 |
| 80 | SCYL2 | 0.70518843 |
| 81 | PDGFRB | 0.69058004 |
| 82 | MYLK | 0.68464593 |
| 83 | FLT3 | 0.67723894 |
| 84 | PLK1 | 0.66757437 |
| 85 | PRKD3 | 0.66197542 |
| 86 | KSR2 | 0.65691931 |
| 87 | LRRK2 | 0.65384950 |
| 88 | HCK | 0.65159281 |
| 89 | DYRK1B | 0.64399820 |
| 90 | JAK1 | 0.62912564 |
| 91 | RPS6KC1 | 0.62510913 |
| 92 | RPS6KL1 | 0.62510913 |
| 93 | GRK6 | 0.61354572 |
| 94 | ZAP70 | 0.61221120 |
| 95 | SIK2 | 0.60728814 |
| 96 | MAP4K1 | 0.59477082 |
| 97 | BUB1 | 0.59403871 |
| 98 | MAP2K2 | 0.59281755 |
| 99 | MET | 0.59224501 |
| 100 | PDK1 | 0.59107053 |
| 101 | MAPK7 | 0.58835252 |
| 102 | CDC7 | 0.58167256 |
| 103 | PAK2 | 0.57623012 |
| 104 | CHEK2 | 0.57290823 |
| 105 | SIK1 | 0.56202707 |
| 106 | MAPK12 | 0.55524490 |
| 107 | GSK3A | 0.54057628 |
| 108 | PAK6 | 0.53677555 |
| 109 | MARK3 | 0.53476895 |
| 110 | IRAK4 | 0.53281785 |
| 111 | TAOK3 | 0.52919371 |
| 112 | EGFR | 0.52421121 |
| 113 | BRAF | 0.52228717 |
| 114 | MAPKAPK2 | 0.52197646 |
| 115 | HIPK2 | 0.51425495 |
| 116 | MAPKAPK3 | 0.51077852 |
| 117 | RET | 0.50905649 |
| 118 | ABL2 | 0.50318108 |
| 119 | TESK2 | 0.50279928 |
| 120 | CAMK1G | 0.49736618 |
| 121 | ROCK2 | 0.49675153 |
| 122 | LIMK1 | 0.49170393 |
| 123 | MAPK1 | 0.47719207 |
| 124 | SGK3 | 0.47266291 |
| 125 | RPS6KA1 | 0.46950404 |
| 126 | EPHB2 | 0.46543147 |
| 127 | LMTK2 | 0.46376884 |
| 128 | MAP3K5 | 0.45653473 |
| 129 | CHEK1 | 0.45059180 |
| 130 | MAP3K7 | 0.44728479 |
| 131 | RIPK4 | 0.44593851 |
| 132 | PAK1 | 0.44391130 |
| 133 | ERBB4 | 0.44189535 |
| 134 | PRKD2 | 0.43725295 |
| 135 | IKBKE | 0.43682398 |
| 136 | ATR | 0.43571149 |
| 137 | CDK2 | 0.42971098 |
| 138 | RAF1 | 0.42811751 |
| 139 | BTK | 0.40612161 |
| 140 | IRAK1 | 0.40268729 |
| 141 | RPS6KA6 | 0.39304647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.74625145 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.54765657 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36911643 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.32867888 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 1.86658100 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86565388 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.75582714 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.66307289 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.60003155 |
| 10 | Apoptosis_Homo sapiens_hsa04210 | 1.58971102 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.54579304 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.54375365 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 1.54370002 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53211534 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 1.41985031 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41190045 |
| 17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.39768297 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.38081024 |
| 19 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37825933 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.37076883 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35982146 |
| 22 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.35510030 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34008999 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32488396 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.28796872 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27866168 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27585072 |
| 28 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.27083279 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.25809673 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.24341767 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24335809 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.24271621 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.19069153 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.17069422 |
| 35 | Bladder cancer_Homo sapiens_hsa05219 | 1.16958677 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.14534986 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.13878660 |
| 38 | Measles_Homo sapiens_hsa05162 | 1.13281057 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.11434558 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 1.11417544 |
| 41 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.10718353 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07858792 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.07443213 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07007262 |
| 45 | Endocytosis_Homo sapiens_hsa04144 | 1.05280735 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.04156886 |
| 47 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.03340535 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02845220 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02552572 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 1.02152805 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.01773231 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99169539 |
| 53 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98981801 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98692979 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.98391594 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98116868 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97873621 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.96834070 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95429110 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92751223 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92574349 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.91609029 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90656333 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.90558401 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.90543487 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.88469151 |
| 67 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88451568 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.86434916 |
| 69 | Base excision repair_Homo sapiens_hsa03410 | 0.86277392 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86062604 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85151408 |
| 72 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84366057 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84011608 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83953837 |
| 75 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82560524 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.82196077 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81895977 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81748510 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80719564 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80336865 |
| 81 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79567524 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79226071 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78576116 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77253603 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76234222 |
| 86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75877433 |
| 87 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75114003 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73213005 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.72857624 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72708681 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71918218 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70264333 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70248998 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69853643 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.67305230 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67222583 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67021832 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66374280 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.65987275 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65317496 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64282360 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63265348 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63041494 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62511882 |
| 105 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62220348 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.62052993 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61237282 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61163162 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60643041 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60617689 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60475625 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59383863 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59297497 |
| 114 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58115574 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57712601 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57702240 |
| 117 | Spliceosome_Homo sapiens_hsa03040 | 0.57566170 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56493801 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56439429 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56349385 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56051786 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55039131 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54698256 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54256451 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54123722 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52890301 |
| 127 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51251031 |
| 128 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51165545 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.50755212 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.49996312 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49543796 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48828327 |
| 133 | Asthma_Homo sapiens_hsa05310 | 0.48505207 |

